Search

everythinglearnresearchcommunity

for

Search:↓

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

IMSG nanoparticles improve vaccine delivery and immune response through hair follicles.

ANp63 is crucial for skin integrity, new filaggrin gene mutations link to eczema, hair can regrow from non-stem cells, sunburns are increasing, and glucocorticoids help treat skin allergies by affecting immune cells.

Children with alopecia areata have immune imbalances and are more likely to have certain health issues.

A woman with severe angioedema improved significantly after treatment with rituximab.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

RXRα is crucial for proper immune response and links diet to immune function.

The nail immune system is similar to hair but different from skin, with fewer immune markers.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

ILC1 cells contribute to hair loss in alopecia areata.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Topical immunotherapy is the best treatment for severe alopecia areata.

Alopesi tedavisinde ilaçlar saç büyümesini teşvik eder ve yeni yaklaşımlar umut vaat eder.

IL-17 is a key target for treating inflammatory skin diseases, especially psoriasis.

Tofacitinib may help treat hair loss in children with alopecia areata.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

A patient got a skin reaction on their hands and feet after using secukinumab for psoriasis.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Cytokine therapy is promising for treating skin conditions like vitiligo and psoriasis.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Immune cells are crucial for hair growth and preventing hair loss.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.